alexa Membranous nephropathy | India | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

  • 2nd Annual Kidney Congress
    Aug 28-30, 2017, Philadelphia, USA
  • 16th European Nephrology Conference
    Oct 02-04, 2017, Barcelona, Spain
  • 16th International Conference on Nephrology
    Nov 02-03, 2017, Atlanta, USA
Read more

Recommended Journals

Relevant Topics

Membranous Nephropathy

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Membranous nephropathy


    Membranous nephropathy 
    is deposition of immune complexes on the glomerular basement membrane (GBM) with GBM thickening. Cause is usually unknown, although secondary causes include drugs, infections, autoimmune disorders, and cancer.Manifestations include insidious onset of edema and heavy proteinuria with benign urinary sediment, normal renal function, and normal or elevated BP.

  • Membranous nephropathy

    Disease pathophysiology: 

    75% of adult and 20% of childhood cases are idiopathic autoimmune disease linked to HLA, caused by antibodies to a renal autoantigen. Secondary cases are associated with cancer (lung, colon, melanoma), hepatitis B/C, malaria, schistosomiasis, drugs (penicillamine, captopril, gold, NSAID), heavy metals, lupus, diabetes, thyroiditis and angiofollicular lymph node hyperplasia. Proteinuria may be due to C5b-C9 (MAC complex of complement)Allograft recurrences represent idiopathic MGN due to IgG4, with different pathogenic mechanism than de novo MGN.

     

  • Membranous nephropathy

    Disease statistics: 

    There were 444 native kidney biopsies performed, 238 males (53.6%) and 206 females (46.7%). The average age of patients was 47.6 years. The most common clinical presentation as an indication for renal biopsy was nephrotic syndrome (52%). Membranous nephropathy (17.5%) was the most common glomerular disease and the most frequent cause (29.8%) of nephrotic syndrome. 

     

  • Membranous nephropathy

    Disease treatment:

    The controversy is mainly related to the toxicity of the therapy and the variable natural course of the disease—spontaneous remission occurs in 40–50% of patients. The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis provides guidance for the treatment of iMN. The guideline suggests that immunosuppressive therapy should be restricted to patients with nephrotic syndrome and persistent proteinuria, deteriorating renal function or severe symptoms. 

  • Membranous nephropathy

    Major research on disease:

    New physiopathological roles for the PLA2R1 receptor in cancer and membranous nephropathy. PLA2R1 is a large transmembrane receptor of 180-kDa that belongs to the superfamily of C-type lectins. It was discovered because of its high affinity for secreted phospholipases A2 (sPLA2), enzymes that play a key role in lipid mediator synthesis.

Expert PPTs

Speaker PPTs

  • Hayam I Gad
    Effects of Pravastatin or 12/15 lipoxygenase pathway inhibitors on indices of Diabetic nephropathy in an experimental model of diabetic renal disease
    PPT Version | PDF Version
 

High Impact List of Articles

Conference Proceedings

adwords